Insomnia Therapeutics Market Outlook, End-User Analysis and Forecast Report till 2025
Global Insomnia Therapeutics Market is anticipated to reach USD 3.45 billion by 2025. Insomnia Therapy implies different patterns of treatment to address trouble with respect to initiation as well as maintenance of sleep. These sleep disorders are termed as “Insomnia”. Insomnia results in non-productive work hours. If left untreated, this condition may lead to a nervous breakdown and/or depression in the patient. The symptoms include daytime sleepiness, low stamina, irritability, and depression. It is a dominant disorder that affects millions of people, globally.
Global Insomnia Therapeutics Market is anticipated to reach USD 3.45 billion by 2025. Insomnia Therapy implies different patterns of treatment to address trouble with respect to initiation as well as maintenance of sleep. These sleep disorders are termed as “Insomnia”. Insomnia results in non-productive work hours. If left untreated, this condition may lead to a nervous breakdown and/or depression in the patient. The symptoms include daytime sleepiness, low stamina, irritability, and depression. It is a dominant disorder that affects millions of people, globally.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
North America accounted for the major share of the Insomnia Therapeutics Market Size in 2016 and will continue to
lead in the forecast period. The factors that could be attributed to the growth include growing aged population, high
adoption of therapeutics for treatment, and increase in awareness about diseases. North America is followed by Asia-
Pacific region. Some of the key players that fuel the growth of the Insomnia Therapeutics Market comprise Sanofi,
Pfizer, Inc., ECR Pharmaceuticals, Merck & Co. Inc., Pernix Therapeutics, Purdue Pharmaceuticals L.P., Eisai, Co. Ltd.,
Vanda Pharmaceuticals, Takeda Pharmaceutical Company Ltd., and Meda Consumer Healthcare Inc. The leading
companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic
growth of the industry.
Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/insomnia-therapeutics-market/request-sample
Market Segment:
Insomnia Therapeutics Market Treatment Type Outlook (Revenue, USD Million, 2014 - 2025)
• Drugs
• Benzodiazepines
• Nonbenzodiazepines
• Antidepressants
• Orexin antagonist
• Melatonin antagonist
• Others
• Devices
Insomnia Therapeutics Market Sales Channel Outlook (Revenue, USD Million, 2014 - 2025)
• Prescription
• Over-the-Counter(OTC)
Insomnia Therapeutics Market Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
Change language